Screening for depression should be ongoing in patients with heart disease, the study's lead author said.
Depression doubled the risk of death for patients with heart disease, whether they develop depression right after learning the news or years later, according to a new study of more than 24,000 patients.
In fact, the study from researchers at Intermountain Medical Center Heart Institute found that depression was the single best predictor of death among patients with cororary artery disease, and remained so even after they controlled for other factors.
The study, published in the European Heart Journal—Quality Care and Clinical Outcomes, found that 15% of the patients were diagnosed with depression at some point after learning they had heart disease.
While most studies screen patients for depression at a single point in time—usually 30 days after a heart event—this study dug deeper, and looked at the relationship between death rate and patients who became depressed at any point after the heart disease diagnosis.
“We’ve completed several depression-related studies and been looking at this connection for many years,” Heidi May, PhD, a cardiovascular epidemiologist at Intermountain, said in a statement. “The data just keeps building on itself, showing that if you have heart disease and depression and it’s not appropriately treated in a timely fashion, it’s not a good thing for your long-term well-being.”
Studies show the conditions feed on each other: depression makes heart disease worse, and vice versa. Patients with heart disease who developed depression were more likely to be young, female, and have diabetes. Many learned of their condition by having a heart attack.
May speculated that depression may reflect how well these patents follow treatment plans, and this may lead to early death. Depression also causes changes in the body.
The takeaway, she said, is that depression can occur long after a heart event. “Continued screening for depression needs to occur. After one year, it doesn’t mean they’re out of the woods.”
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More